News
“Sinaloa está identificado como el estado con mejor cobertura de vacunación a nivel nacional, Sinaloa superó el 100%, va en ...
Current therapies for chronic hepatitis B virus (HBV) infection can effectively suppress viral replication but do not achieve ...
Dr. Jaime Jesús Pérez-Martín, presidente de la Asociación Española de Vacunología (AEV) y Dr. Fernando Moraga-Llop, vocal sénior y portavoz de la Asociación Española de Vacunología (AEV) ...
2d
Clinical Trials Arena on MSNVir’s hepatitis B combo falls short in Phase II trialVir is holding off on advancing the combination therapy to Phase III trials until it secures a development partner.
Discover a study that raises important concerns about the long-term mental health of individuals with resolved HBV infection.
Hosted on MSN4d
Arbutus Biopharma Showcases Promising Results for Hepatitis B Therapies at EASL Congress 2025WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) recently presented compelling data on its investigational ...
Viral hepatitis is a leading cause of liver disease, liver cancer and liver transplant in the United States and is a focus of an annual national awareness campaign that occurs ...
El secretario del Departamento de Salud (DS), Víctor Ramos Otero, junto a más funcionarios, presentará alternativas para ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results